SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPB - Cypress BioScience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenhott who wrote (576)6/9/2009 11:27:13 AM
From: Arthur Radley  Read Replies (1) of 586
 
CYPB) Back in January the FDA approved Savella for fibromyalgia. Forest is their marketing partner. With approval the stock bounced up, but then traded back down. Lately the stock has seen a little bounce and is back near 52 week high. It appears the Rx rate with the drug now being launched is as follows:
Week 1- 60 Scripts
Week 2- 502
Week 3- 1129
Week 4 - 1812
Week 5 - 2219

This appears to be a nice launch pattern, does anyone have any experience in this market and how this launch appears to them
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News